Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Krisztina Z, Hanley"'
Autor:
Alexandra A. Wolfarth, Xu Liu, Trevor M. Darby, Darra J. Boyer, Jocelyn B. Spizman, Joshua A. Owens, Bindu Chandrasekharan, Crystal R. Naudin, Krisztina Z. Hanley, Brian S. Robinson, Eric A. Ortlund, Rheinallt M. Jones, Andrew S. Neish
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 10, Iss 4, Pp 713-727 (2020)
Background & Aims: The intestinal epithelium must be resilient to physiochemical stress to uphold the physiological barrier separating the systemic compartment from the microbial and antigenic components of the gut lumen. Identifying proteins that me
Externí odkaz:
https://doaj.org/article/4a0ec09a3c3648728968dcc3d9a1343a
Publikováno v:
International Journal of Gynecological Pathology. 40:501-509
Carcinosarcomas (CSs) of the endometrium are biphasic malignancies, composed of high-grade carcinomatous and sarcomatous components. Surgical stage and pathologic characteristics are the most important prognostic findings, with a 5-yr survival of 15%
Autor:
Lisa Flowers, Marina Mosunjac, Mohammad K. Mohammad, Gabriela Oprea, Talaat Tadros, Krisztina Z. Hanley, Ashley Monsrud, Mario Mosunjac, Uma Krishnamurti
Publikováno v:
Journal of Lower Genital Tract Disease. 24:69-74
Objective Morphologic diagnosis and grading of anal squamous intraepithelial lesions (ASILs) are challenging. In this study, we investigated interobserver variability and p16 utility in accurately grading anal SIL. Materials and methods Six pathologi
Autor:
Nada Shaker, Philip P.C. Ip, Nuha Shaker, Andres A. Roma, Lien N. Hoang, Jonathan L. Hecht, Abrar G. Alghamdi, Vinita Parkash, Raji Ganesan, Krisztina Z. Hanley, Oluwole Fadare, Hussain Abubakr
Publikováno v:
Modern Pathology. 32:1847-1860
Uterine yolk sac tumors have gained increased recognition in recent years. The current study is a multi-faceted examination of yolk sac tumor-like phenotypes in endometrial tumors, based on an analysis of 3 groups of uterine tumors: Group 1: 9 endome
Publikováno v:
International Journal of Gynecological Pathology. 38:485-492
GATA binding protein 3 (GATA3) immunohistochemistry is primarily used as a marker of breast and urothelial differentiation, particularly in metastatic settings. In the gynecologic tract it also serves a robust marker for mesonephric and trophoblastic
Autor:
Marina Mosunjac, Krisztina Z. Hanley
Publikováno v:
Surgical Pathology Clinics. 12:587-620
Ovarian sex cord-stromal tumors are uncommon tumors and clinically differ from epithelial tumors. They occur across a wide age range and patients often present with hormone-related symptoms. Most are associated with an indolent clinical course. Sex c
Autor:
Charles M. Quick, John F. DeCoteau, Nick Baniak, Mary Kinloch, Vinita Parkash, Jonathan L. Hecht, Sharon X. Liang, Oluwole Fadare, Elke A. Jarboe, Martin Köbel, Krisztina Z. Hanley, Wenxin Zheng, Katja Gwin
Publikováno v:
American Journal of Surgical Pathology. 43:531-537
Endometrial clear cell carcinoma (ECCC) is an uncommon histotype without unique identified molecular alterations. Recently, The Cancer Genome Atlas molecular subtypes have been reported in ECCC. ECCC cases were collected from 11 institutions with dia
Publikováno v:
Seminars in Diagnostic Pathology. 36:11-15
Developmental abnormalities and malformations of the breast are rare and encompass a variety of genetic, syndromic, acquired and sporadic conditions. Abnormalities in development may include irregularities in the nipple areolar complex and/or the und
Publikováno v:
AJR. American journal of roentgenology. 216(6)
OBJECTIVE. The purpose of our study was to evaluate the upgrade rate of calcified lobular neoplasia (LN) versus incidental noncalcified classic LN found on core needle biopsy performed for the evaluation of suspicious calcifications. MATERIALS AND ME
Autor:
Kamaljeet Singh, Lajos Pusztai, Jane E. Brock, Anja C. Roden, Krisztina Z. Hanley, Gang Han, Hannah Wen, Dylan V. Miller, Mirna Podoll, Beth T. Harrison, Emily Reisenbichler, Shi Wei, Omar Hameed, Kimberly Cole, Fahad Shabbir Ahmed, Vasiliki Pelekanou, Andrew M. Bellizzi, M. Gabriela Kuba, David L. Rimm, Vesal Yaghoobi, Veerle Bossuyt, Amy Ly, Oluwole Fadare, Mary Ann Sanders
Publikováno v:
Mod Pathol
The US Food and Drug Administration (FDA) approved the PD-L1 immunohistochemical assay, SP142, as a companion test to determine eligibility for atezolizumab therapy in patients with advanced triple negative breast cancer (TNBC) but data in lung cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edcd17168618619e386a84cc437111d0
https://europepmc.org/articles/PMC8366569/
https://europepmc.org/articles/PMC8366569/